DCRI and Responsum Health Announce Collaboration to Connect Uterine Fibroids Patients
Responsum Health, a company that creates patient platforms for chronic diseases, will create a patient-centered information portal and community hub that will synchronize with the DCRI’s COMPARE-UF
DCRI Study Finds New Predictor of Health Care Costs
New findings from the DCRI suggest that how military service members interpret their pain may be able to predict pain-related costs and total medical costs.
DCRI, Cerner Partner on New Study Using Real-World Data
The pilot project and study, called the Learning Registry, will use electronic health records from the Cerner Learning Health Network to evaluate the use and potential impact of proven therapies fo
Open Data Critical to Clinical Research
In a recent Perspective piece, the DCRI’s Frank Rockhold, PhD, outlines why data sharing is so important to the future of clinical research and shares suggestions for making the process more efficient.
Duke Symposium Showcases Diverse Obesity Research, Patient Experiences
Over 100 researchers, clinicians, community members, and patients came together to spotlight obesity-related research during the Transforming Obesity Research at Duke Symposium, which was co-hosted
DCRI Researchers Weigh In On Patient Data-Sharing
Sharing data across clinical trials and cohort studies is key to continuous knowledge generation and healthcare innovation, according to a recent discussion paper from the National Academy of Medicine (NAM) that features contributions from the DCRI’s Eric Peterson, MD, MPH, FAHA, FACC, and Robert Califf, MD, MACC.
Warfarin Control Measures May Not Accurately Predict Risk in Atrial Fibrillation Patients
A metric typically used to determine doses of warfarin in patients with atrial fibrillation, international normalized ratio (INR), was once thought to be a potential indicator of future risk levels for bleeding or thrombotic events. However, research published recently in JAMA Cardiology by the DCRI’s Sean Pokorney, MD, MBA, suggests that historical INR values may not be the most accurate predictor of future events.
Medical Misinformation Causes Underuse of Statins
In a recent Viewpoint piece published in JAMA Cardiology, the DCRI’s Ann Marie Navar said that the proliferation of medical misinformation around statins is causing often misguided fears about statins, leading patients to refuse or stop treatment.
The DCRI Welcomes Three Former Fellows As New Faculty
The new faculty represent the pediatrics, nephrology, and musculoskeletal therapeutic areas.